T2D
November 21, 2013

Systemic metabolic markers and myocardial glucose uptake in type 2 diabetic and coronary artery disease patients

Badeau et al. Annals of Medicine 2014;46(1):18-23

This paper studies the effects of rosiglitazone treatment on circulating low-molecular-weight metabolites and lipoprotein subclasses and lipids that are associated with type 2 diabetes.